Sinopsis
Oncology Information Group is a global resource for the latest updates in oncology advancements. Subscribe to our podcast to receive the latest updates as they become available.
Episodios
-
![Dr. Paulo Lages - Overview in Prostate Cancer]()
Dr. Paulo Lages - Overview in Prostate Cancer
22/02/2017 Duración: 02minDr. Paulo Lages - Overview in Prostate Cancer
-
![Dr. Luiz Bruno - Highlights from Day 1]()
Dr. Luiz Bruno - Highlights from Day 1
22/02/2017 Duración: 04minDr. Luiz Bruno - Highlights from Day 1
-
![Dr. Fabio Schutz - Highlights in Renal Cell Carcinoma]()
Dr. Fabio Schutz - Highlights in Renal Cell Carcinoma
22/02/2017 Duración: 03minDr. Fabio Schutz - Highlights in Renal Cell Carcinoma
-
![Dr. Daniel Herchenhorn - Poster Sessions Highlights]()
Dr. Daniel Herchenhorn - Poster Sessions Highlights
22/02/2017 Duración: 06minDr. Daniel Herchenhorn - Poster Sessions Highlights
-
![Igor Stukalin - Fourth-line targeted therapy in MRCC]()
Igor Stukalin - Fourth-line targeted therapy in MRCC
22/02/2017 Duración: 02minIgor Stukalin - Fourth-line targeted therapy in MRCC
-
![Dr. Toni Choueri - Update in Kidney Cancer]()
Dr. Toni Choueri - Update in Kidney Cancer
22/02/2017 Duración: 03minDr. Toni Choueri - Update in Kidney Cancer
-
![Dr. Steven Yip - Immuno-oncology Agents in MRCC]()
Dr. Steven Yip - Immuno-oncology Agents in MRCC
22/02/2017 Duración: 02minDr. Steven Yip - Immuno-oncology Agents in MRCC
-
![Dr. Eric Jonasch - Alternate Sunitinib Schedule]()
Dr. Eric Jonasch - Alternate Sunitinib Schedule
22/02/2017 Duración: 01minDr. Eric Jonasch - Alternate Sunitinib Schedule
-
![Dr. Daniel Heng - Renal Cell Carcinoma Updates]()
Dr. Daniel Heng - Renal Cell Carcinoma Updates
22/02/2017 Duración: 03minDr. Daniel Heng - Renal Cell Carcinoma Updates
-
![Dr. Daniel George - UPWARD Study]()
-
![Dr. Denis Landaverde - Nueva Evidencia del uso de Inibidores de CDK 416 en Cancer Metastatico RH + HER2 - (Spanish)]()
Dr. Denis Landaverde - Nueva Evidencia del uso de Inibidores de CDK 416 en Cancer Metastatico RH + HER2 - (Spanish)
12/12/2016 Duración: 01minDr. Denis Landaverde - Nueva Evidencia del uso de Inibidores de CDK 416 en Cancer Metastatico RH + HER2 - (Spanish)
-
![Dr. Glauber Leitão - Highlights From Day 1 (Portuguese)]()
Dr. Glauber Leitão - Highlights From Day 1 (Portuguese)
12/12/2016 Duración: 01minDr. Glauber Leitão - Highlights From Day 1 (Portuguese)
-
![Dr. Darley de Lima Ferreira Filho - Cirurgia Day 1 (Portuguese)]()
Dr. Darley de Lima Ferreira Filho - Cirurgia Day 1 (Portuguese)
12/12/2016 Duración: 02minDr. Darley de Lima Ferreira Filho - Cirurgia Day 1 (Portuguese
-
![Dr. Felipe Zerwes - Cirurgia Day 2 (Portuguese)]()
Dr. Felipe Zerwes - Cirurgia Day 2 (Portuguese)
12/12/2016 Duración: 02minDr. Felipe Zerwes - Cirurgia Day 2
-
![Dr. Carlos Barrios - Highlights from Day 2 (Portuguese)]()
Dr. Carlos Barrios - Highlights from Day 2 (Portuguese)
12/12/2016 Duración: 04minDr. Carlos Barrios - Highlights from Day 2
-
![Dr. Gilberto Amorim - Hot Topics em Câncer de Mama (Portuguese)]()
Dr. Gilberto Amorim - Hot Topics em Câncer de Mama (Portuguese)
12/12/2016 Duración: 06minDr. Gilberto Amorim - Hot Topics em Câncer de Mama (Portuguese)
